Hypertension, Antihypertensive Therapy, and Erectile Dysfunction

Erectile dysfunction represents a common problem in the male hypertensive population. Both erectile dysfunction and hypertension share common pathophysiologic pathways such as atherosclerosis and endothelial dysfunction. Furthermore, traditional cardiovascular risk factors affect both conditions. No...

Full description

Saved in:
Bibliographic Details
Published in:Angiology 2006-01, Vol.57 (1), p.47-52
Main Authors: Papatsoris, Athanasios G., Korantzopoulos, Panagiotis G.
Format: Article
Language:English
Subjects:
Antihypertensive Agents - adverse effects
Antihypertensive Agents - therapeutic use
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood. Blood coagulation. Reticuloendothelial system
Cardiology. Vascular system
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
Decision Making
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Erectile Dysfunction - etiology
Humans
Hypertension - complications
Hypertension - drug therapy
Male
Medical sciences
Pharmacology. Drug treatments
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Erectile dysfunction represents a common problem in the male hypertensive population. Both erectile dysfunction and hypertension share common pathophysiologic pathways such as atherosclerosis and endothelial dysfunction. Furthermore, traditional cardiovascular risk factors affect both conditions. Notably, several antihypertensive medications seem to adversely affect erectile function whereas others may exert neutral or even favorable effects. Thus, the regular and meticulous clinical evaluation of hypertensive patients, as well as individualization of anti-hypertensive therapy, are important steps in the effective management of such patients. In addition, the administration of phosphodiesterase-5 inhibitors or apomorphine has excellent efficacy and safety profile in hypertensive patients irrespective of taking or not taking anti-hypertensive medications.
ISSN:0003-3197
1940-1574
DOI:10.1177/000331970605700107